Dialysate and substitution fluids for patients treated by continuous forms of renal replacement therapy

Contributions to Nephrology

Volumn 132, Issue , 2001, Pages 313-322

  Davenport, A ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ELECTROLYTE;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; HEMOFILTRATION; HUMAN; INSTRUMENT STERILIZATION; METABOLISM; PH; REVIEW; TEMPERATURE;

ACID-BASE EQUILIBRIUM; ANTICOAGULANTS; ELECTROLYTES; HEMOFILTRATION; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY FAILURE, ACUTE; STERILIZATION; TEMPERATURE;

EID: 0035532684     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (30)

1. Kramer P, Wigger W, Rieger J, Mathaei D, Scheler F: Arteriovenous hemofiltration: A new and simple method for the treatment of overhydrated patients resistant to diuretics. Klin Wochenschr 1977;5:1121-1122.
2. Storck M, Hartl W, Zimmerer E, Inthorn D: Comparison of pump-driven and spontaneous haemofiltration in post-operative acute renal failure. Lancet 1991;337:452-455.
3. Ronco C, Bellomo R, Hamel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure. Lancet 2000;356:26-30.
4. Grootendorst AF, van Saase JLCM: Blood purification by hemofiltration in septic shock and multiple organ dysfunction syndrome patients; in Bellomo R, Ronco C (eds): Update in Intensive Care and Emergency Medicine. Heidelberg, Springer 1995, vol 20, pp 311-325.
5. Davenport A: Hemofiltration in patients with fulminant hepatic failure. Lancet 1991;338:1604.
6. Davenport A, Kirby SA: Hemofiltration/dialysis treatment in patients with acute renal failure. Care Critically Ill 1996;12:54-58.
7. Veech RL: The untoward effects on anions of dialysis fluids. Kidney Int 1991;34:587-589.
8. Bradley JR, Evans DB, Gore SM, Cowley AJ: Is dialysis hypotension caused by an abnormality in venous tone? Br Med J 1988;296:1634-1637.
9. Katzarski KS: Fluid state and blood pressure control in patients on maintenance hemodialysis; thesis, Stockholm 1999.
10. Wright DA, Forni LG, Carr LG, Treacher DF, Hilton PJ: Use of continuous hemofiltration to assess the rate of lactate metabolism in acute renal failure. Clin Sci 1996;90:507-510.
11. Davenport A, Will EJ, Davison AM: Hyperlactatemia and metabolic acidosis during hemofiltration using lactate-buffered fluids. Nephron 1991;59:461-465.
12. Nimmo GR, Grant IS, Mackenzie SJ: Lactate and acid base changes in the critically ill. Post Grad Med J 1991;67(suppl 1):S56-S61.
13. Hilton PJ, Taylor J, Forni LG, Treacher DF: Bicarbonate-based hemofiltration in the management of acute renal failure with lactic acidosis. Q J Med 1988;91:279-283.
14. Davenport A, Worth DP, Will EJ: Hypochloremic alkalosis after high flux continuous hemofiltration and continuous arterio-venous hemofiltration with dialysis. Lancet 1988;i:658.
15. Levrault J, Ciebiera JP, Jambou P, Ichai C, Labib Y, Grimaud D: Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. Crit Care Med 1997;25:58-62.
16. Thomas AN, Guy JM, Kishen R, Bowles BMJ, Vadgama P: Comparison of lactate and bicarbonate-buffered hemofiltration fluids: Use in critically ill patients. Nephrol Dial Transplant 1997;12:1212-1217.
17. Heering P, Ivens K, Thümer O, Moergera S, Heintzen M, Passlick-Deetjen J, Willers R, Strauber BE, Grabenensee B: The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure. Intensive Care Med 1999;25:1244-1251.
18. MacLean AG, Davenport A, Cox D, Sweny P: Effects of continuous haemodiafiltration against lactate-buffered and lactate-free dialysate in patients with and without liver dysfunction. Kidney Int 2000;58:1765-1772.
19. Manns M, Sigler MH, Teehan BP: Continuous renal replacement therapies: An update. Am J Kidney Dis 1998;32:185-200.
20. Thomas AN, Guy JM, Kishen R, Geraghty IF, Bowles BJM, Vadgana P: Comparison of lactate- and bicarbonate-buffered hemofiltration fluids: Use in critically ill patients. Nephrol Dial Transplant 1997;12:1212-1217.
21. Kierdorf HP, Leue C, Arns S: Lactate-or bicarbonate-buffered solutions in continuous extracorporeal renal replacement therapies. Kidney Int 1999;56(suppl 72):S32-S36.
22. Zimmerman D, Cotman P, Ting R, Karanicolas S, Tobe SW: Continuous veno-venous haemodialysis with a novel bicarbonate dialysis solution: Prospective cross-over comparison with a lactate-buffered solution. Nephrol Dial Transplant 1999;14:2387-2391.
23. Jennett S, Forrest JB, Herd DJ: Cardiovascular effects of sodium bicarbonate injections. Br J Anaest 1976;16:223-224.
24. Goldsmith DJA, Forni LG, Hilton PJ: Bicarbonate therapy and intracellular acidosis. Clin Sci 1997;93:593-598.
25. Mehta RL, McDonald BR, Aguilar MM, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990;38:976-981.
26. Palson R, Niles JL: Regional citrate anticoagulation in continuous veno-venous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999;55:1991-1997.
27. Mehta RL, McDonald B, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis. Contrib Nephrol. Basel, Karger, 1991, vol 93, pp 210-214.
28. Favre H, Martin Y, Stoermann C: Anticoagulation in continuous extracorporeal renal replacement therapy. Semin Dial 1996;9:112-118.
29. Nowak MA, Campbell TE: Profound hypercalcaemia in continuous veno-venous hemofiltration dialysis with trisodium citrate anticoagulation and hepatic failure. Clin Chem 1997;43:412-413.
30. Yagi N, LeBlanc M, Sakai K, Wright EJ, Paganini EP: Cooling effect of continuous renal replacement therapies in critically ill patients. Am J Kidney 4 Dis 1999;32:1023-1030.